Log In
Print
BCIQ
Print
Print this Print this
 

topiramate (Qudexy XR) (USL255)

  Manage Alerts
Collapse Summary General Information
Company Upsher-Smith Laboratories Inc.
DescriptionExtended-release formulation of topiramate, a sodium channel blocker, GABA receptor agonist and AMPA receptor antagonist
Molecular Target GABA receptor ; Sodium channel
Mechanism of ActionAMPA receptor antagonist; GABA receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationEpilepsy
Indication DetailsAdjunctive treatment of epilepsy in patients with refractory partial-onset seizures; Initial monotherapy in patients >=10 years of age with partial onset seizures or primary generalized tonic-clonic seizures
Regulatory Designation

U.S. - Special Protocol Assessment (Adjunctive treatment of epilepsy in patients with refractory partial-onset seizures)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today